Frankfurt - Delayed Quote EUR

BioHarvest Sciences Inc. (8MV0.F)

5.70

+0.32

+(5.95%)

At close: May 9 at 8:08:39 AM GMT+2

BioHarvest Sciences Reports First Quarter 2025 Financial Results

First Quarter Revenues Grew 47% to $7.9 Million, Exceeding Management Guidance Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the first quarter ended March 31, 2025.First Quarter & Subsequent 2025 Operational HighlightsAll figures stated in this news release are in U.S. dollars

Newsfile 2 days ago

BHST
BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

Successful Progression Validates Botanical Synthesis Platform for a Variety of Molecule Types Rehovot, Israel--(Newsfile Corp. - May 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Company's previously announced CDMO contract with a Nasdaq-listed pharmaceutical company has progressed from Stage 1 to Stage 2 - providing further validation of the vers

Newsfile 6 days ago

BHST
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

Rehovot, Israel--(Newsfile Corp. - May 1, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the first quarter ended March 31, 2025 after market close on Thursday, May 15, 2025.Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on Thursday, May 15, 2025 to discuss the Company's ...

Newsfile 17 days ago

BHST
BioHarvest Sciences Full Year 2024 Earnings: EPS Misses Expectations

BioHarvest Sciences ( NASDAQ:BHST ) Full Year 2024 Results Key Financial Results Revenue: US$25.2m (up 99% from FY...

Simply Wall St. last month

BHST
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to $25.2 MillionCDMO Division Secures Anchor Partnership with Tate & Lyle to Develop Next Generation of Plant-Based SweetenersRehovot, Israel--(Newsfile Corp. - March 31, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its f

Newsfile last month

BHST
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

Rehovot, Israel--(Newsfile Corp. - March 17, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024 after market close on Monday, March 31, 2025.Management will host an investor conference call and webcast at 4:30 p.m. Eastern time on Monday, March 31, 2025, to ...

Newsfile 2 months ago

BHST
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 6, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the 37th Annual Roth Conference taking place on March 16-18, 2025.CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the duration of the event. 37th Annual Roth Con

Newsfile 2 months ago

BHST
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest's Future Olive Cell Product Targeting Liver Health Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today announced new 'in vitro' test results for the Company's proprietary new Olive Ce

Newsfile 2 months ago

BHST
BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit

With the business potentially at an important milestone, we thought we'd take a closer look at BioHarvest Sciences...

Simply Wall St. 2 months ago

BHST
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

Commercial success of VINIA validates the power of BioHarvest's patented Botanical Synthesis technology to produce valuable plant-based Compounds at industrial scale Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 18, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that its Red Grape Cell composition - known commercially as VINIA® - h

Newsfile 2 months ago

BHST
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the WeBull Consumer Stocks Virtual Webinar taking place on February 18, 2025.CEO Ilan Sobel is scheduled to present at the event. Following the webinar, a replay link to the pre

Newsfile 3 months ago

BHST
BioHarvest Announces Appointment of Sharon Malka to Board of Directors

Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the Board Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 22, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that Mr. Sharon Malka has agreed to serve as an independent director of BioHarvest. The appointment is effective immediately.

Newsfile 3 months ago

BHST
OTC Markets Group Announces Quarterly Index Performance and Rebalancing

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for 12,000 U.S. and global securities, today announced the fourth quarter 2024 performance and quarterly rebalancing of the OTCQX® and OTCQB® indexes, including the OTCQX Canada Index and the OTCQX Dividend Index. The OTCQX Composite Index (.OTCQX), a benchmark for the overall OTCQX Best Market, was down 9.8% in Q4 2024. 32 new companies joined the Index while 31 companies we

GlobeNewswire 3 months ago

ADUR

TZUP

TSSI
BioHarvest Issues Shareholder Letter and Provides Corporate Update

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel.Dear Fellow Shareholders,2024 can be summarized as a year of transformation and growth for BioHarvest, where we introduced our new CDMO Services division -

Newsfile 4 months ago

BHST
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

New collaboration to pioneer next generation of plant-based ingredients for healthier food and beverages London, United Kingdom and Vancouver, British Columbia--(Newsfile Corp. - December 11, 2024) - Tate & Lyle PLC ('Tate & Lyle'), a world leader in ingredient solutions for healthier and tastier food and beverages, and BioHarvest Sciences (NASDAQ: BHST) (CSE: BHSC) ('BioHarvest'), leaders in Botanical Synthesis, announce a pioneering new partnership to develop the next-generation of proprietary

Newsfile 5 months ago

BHST
Diamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST, CNSX: BHSC)

New York, NY, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST, CNSX: BHSC) Diamond Equity Research, an equity research firm with a focus on small capitalization public companies has released an Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST, CNSX: BHSC). The update note includes detailed information on the BioHarvest Sciences’ financial results, operational updates, business model, management commentary, valuation, a

GlobeNewswire 5 months ago

BHST
BioHarvest Sciences Reports Third Quarter 2024 Financial Results

Third Quarter 2024 Revenue Increased 101% Year-over-Year to Over $6.5 Million, Exceeding Management Guidance Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the third quarter ended September 30, 2024.Third Quarter & Subsequent 2024

Newsfile 5 months ago

BHST
BioHarvest Launches VINIA SuperFood Functional Tea Line

Incremental Product Launch Addresses $3.3 Billion North American Functional Tea Market Opportunity with First SuperFood Tea Infused with Piceid Resveratrol Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced the launch of its highly anticipated VINIA® infused teas - a line of

Newsfile 5 months ago

BHST
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place on December 3, 2024.CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional i

Newsfile 5 months ago

BHST
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 18, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the third quarter ended September 30, 2024 after market close on Monday, November 25, 2024.Management will host an investor conference call at 4:30 p.m. Eastern time on Monday, Novem

Newsfile 5 months ago

CNVCF

Performance Overview

Return	8MV0.F	S&P 500 (^GSPC)
YTD	--	+1.30%
1-Year	+8.57%	+12.48%
3-Year	-22.45%	+48.66%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

BioHarvest Sciences Inc. (8MV0.F)

BioHarvest Sciences Reports First Quarter 2025 Financial Results

BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company

BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time

BioHarvest Sciences Full Year 2024 Earnings: EPS Misses Expectations

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time

BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18

BioHarvest Announces Appointment of Sharon Malka to Board of Directors

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

BioHarvest Issues Shareholder Letter and Provides Corporate Update

Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology

Diamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST, CNSX: BHSC)

BioHarvest Sciences Reports Third Quarter 2024 Financial Results

BioHarvest Launches VINIA SuperFood Functional Tea Line

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time

Performance Overview